Placenta, Umbilical Cord, Foetus Damage and Abortion caused by Endotoxin via miR-155 disruption of CD34 cells
Covid19 mRNA jabs carry Endotoxin to the Placenta, Umbilical Cord and Foetus. CD34 Diseases resulting are published in thousands of peer-reviewed papers.
Recently a paper by Xinhua Lin and coworkers created some excitement by identifying Covid19 Jab mRNA in 2 women who submitted to the experimental procedure late in pregnancy.1 One woman had Pfizer and the other had Moderna as their last jab.
While this is an important contribution, I consider one of the papers they reference more important, namely that of Estep and coworkers2, who found that Hematopoietic Stem Progenitor Cells (HSPCs) in Human Umbilical Cord Blood (UCB) “decreased significantly in donors with previous SARS-CoV-2 infection and more so with COVID-19 vaccination via the induction of apoptosis, likely mediated by IFN-γ-dependent pathways.”
My friend Doorless Carp also considers the paper by Estep and coworkers to be important reading.3
They studied CD34 cells in detail. Over 1,650 different CD34 Diseases have resulted in thousands of peer-reviewed papers.4
Here is the Estep graphical abstract:
The known CD34 diseases relevant to Pregnancy include:
Abortion (Spontaneous); Abruptio Placentae; Maternal Death; Perinatal Death; Sudden Infant Death; Chromosome Disorders; Congenital Abnormalities; Inborn Genetic Disorders; Waldenstrom Macroglobulinemia; Delayed effects of prenatal exposure; Embryo Loss; Failure to Thrive; Fetal Nutrition Disorders; Infant Death; Fetal Growth Retardation; Fetal Macrosomia; Male Infertility; Oligospermia; Genetic Transloaction; Neonatal Abstinence Syndrome; Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes; Pregnancy Complications; Pregnancy-Induced Hypertension; Vulvovaginal Candidiasis; Gynecomastia; Uterine Anomalies; Uterine Hemorrhage; Pediatric Obesity; Juvenile Myoclonic Epilepsy; Lactation Disorders; Friedreich Ataxia; Antiphospholipid Syndrome; Ovarian Hyperstimulation Syndrome; Dandy-Walker Syndrome; Menstruation Disturbances; Neoplastic Pregnancy Complications; Endometriosis; Ovarian Epithelial Cancer; Ovarian Cysts; Premature Obstetric Labor; Pervasive Child Development Disorders; Jaundice; Fetal Alcohol Spectrum Disorders; Gestational Weight Gain; Spina Bifida Cystica; Autism Spectrum Disorder; Cleft Lip
Readers are encouraged to explore these and other CD34 Diseases.
miR-155 impacts your CD34 cells
Previously I informed Peter McCullough and other cardiologists, and nurse instructor John Campbell, that I know that they know about Endotoxin induced Heart Damage via upregulation of microRNA miR-155 by Endotoxin in Covid19 jabs.5
In 2007 excellent work by Georgantas and coworkers6 demonstrated that, as they predicted, miR-155 transduction greatly reduced Myeloid and Erythroid colony formation of normal Human HSPCs. I mentioned this in my article on Endotoxin induced miR-155 causing Shingles in jabbees.7
Here is their scheme:
Moderna very interested in CD34 cells
In their 2017 patent, Moderna8 cites 4 papers relating to CD34 cells, so I will have a look at them later.
Pfizer and BioNTech also very interested in CD34 cells
During its Covid19 jab trial, Pfizer reported that a 77-year-old lady developed Acute Myeloid Leukemia9 and used CD34 cells as diagnostic test.
Nobel Prize winners and Pfizer BioNTech technology developers experimented in 2017 with CD34 in attempts to protect Mice for hours against HIV-1 infection and proposed weekly mRNA in LNP jabs for Humans.10
BioNTech reported11 to the US Securities Commission:
Cell Therapy Products. We have end-to-end capabilities and over 20 years of experience in cell therapy manufacturing. Our manufacturing process for cellular products involves the isolation of primary human cells and subpopulations, including CD34+ and CD3+ cells. We engage in the culturing, expansion and genetic modification of primary human cells as well as mammalian cell lines. Our processes include vector production for transfection of cells with CARs, cell banking and cryopreservation.
Genetically Modified CD34 cell Jabs
Beware further GMO experiments involving “edited” CD34 cells.12
Reached the email length limit, so will expand after reader comments.
Xinhua Lin, Bishoy Botros, Monica Hanna, Ellen Gurzenda, Claudia Manzano De Mejia, Martin Chavez and Nazeeh Hanna. 2024. Transplacental Transmission of the COVID-19 Vaccine mRNA: Evidence from Placental, Maternal and Cord Blood Analyses Post-Vaccination.
Benjamin K. Estep, Charles J. Kuhlmann, Satoru Osuka, Gajendra W. Suryavanshi, Yoshiko Nagaoka-Kamata, Ciearria N. Samuel, Madison T. Blucas, Chloe E. Jepson, Paul A. Goepfert, and Masakazu Kamata. 2022. Skewed fate and hematopoiesis of CD34+ HSPCs in umbilical cord blood amid the COVID-19 pandemic.
US Comparative Toxicogenomics Database. CD34 Diseases. https://ctdbase.org/detail.go?type=gene&acc=947&view=disease
Robert W. Georgantas III, Richard Hildreth, Sebastien Morisot, Jonathan Alder, Chang-gong Liu, Shelly Heimfeld, George A. Calin, Carlo M. Croce and Curt I. Civin. 2007. CD34 hematopoietic stem-progenitor cell microRNA expression and function: A circuit diagram of differentiation control. https://www.pnas.org/doi/abs/10.1073/pnas.0610983104
Stephane Bancel, Tirtha Chakraborty, Antonin de Fougerolles, Sayda M. Elbashir, Matthias John, Atanu Roy, Susan Whoriskey, Kristy M. Wood, Paul Hatala, Jason P. Schrum, Kenechi Ejebe, Jeff Lynn Ellsworth, Justin Guild. 2017. US Patent US9587003B2. Modified polynucleotides for the production of oncology-related proteins and peptides. https://patents.google.com/patent/US9587003B2/en
Norbert Pardi, Anthony J. Secreto, Xiaochuan Shan, Fotini Debonera, Joshua Glover, Yanjie Yi, Hiromi Muramatsu, Houping Ni, Barbara L. Mui, Ying K. Tam, Farida Shaheen, Ronald G. Collman, Katalin Karikó, Gwenn A. Danet-Desnoyers, Thomas D. Madden, Michael J. Hope and Drew Weissman. 2017. Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge. https://www.nature.com/articles/ncomms14630
Form 20-F for BioNTech SE filed 27 March 2023.
David L DiGiusto, Paula M Cannon, Michael C Holmes, Lijing Li, Anitha Rao, Jianbin Wang, Gary Lee, Philip D. Gregory, Kenneth A Kim, Samuel B Hayward, Kathleen Meyer, Colin Exline, Evan Lopez, Jill Henley, Nancy Gonzalez, Victoria Bedell, Rodica Stan, John A Zaia. 2016. Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cells. https://www.cell.com/molecular-therapy-family/methods/fulltext/S2329-0501(16)30194-2
the more I read about it, the more it is obvious that a rather benign virus has been used to scare the world population into becoming mice in a giant lab, aiming at poisoning as many as possible, making women infertile, and indeed, progressing with depopulation. I suppose it is almost impossible to esteem the damage these injections have done.